Andrew P. Weng

15.4k citations

100 papers · 9.0k indexed · 4 hit papers · h-index 32

Molecular Biology top 1%
Oncology top 1%
Pathology and Forensic Medicine top 0.5%
Hematology top 0.5%
Immunology top 2%

Co-authors: Jon C. Aster Stephen C. Blacklow Adolfo A. Ferrando A. Thomas Look Cheryll Sanchez-Irizarry Lewis B. Silverman John P. Morris Woojoong Lee
Topics: Lymphoma Diagnosis and Treatment (28 papers)Acute Lymphoblastic Leukemia research (20 papers)Epigenetics and DNA Methylation (16 papers)
Cited by: Hematology Genetics Molecular Biology
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Canada United States France

In The Last Decade

Andrew P. Weng

95 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia

2004 2.0k citations Andrew P. Weng, Adolfo A. Ferrando et al. Science profile →
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

2002 1.8k citations Margaret A. Shipp, Andrew P. Weng et al. profile →
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma

2006 673 citations Andrew P. Weng, Carlos G. Rodríguez et al. profile →
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth

2006 639 citations Teresa Palomero, Wei Keat Lim et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Andrew P. Weng

Since Specialization

Citations

This map shows the geographic impact of Andrew P. Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Weng more than expected).

Fields of papers citing papers by Andrew P. Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Weng. The network helps show where Andrew P. Weng may publish in the future.

Co-authorship network of co-authors of Andrew P. Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Weng. A scholar is included among the top collaborators of Andrew P. Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Weng. Andrew P. Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphocytic Variant Hypereosinophilic Syndrome: Case Series From a Tertiary Referral Center in Canada 2025 ·eJHaem ·Xiu Q. Wang,Kevin E. Shopsowitz,(unknown),Xuehai Wang,Erica A. Peterson,Andrew P. Weng,Luke Y. C. Chen	2
2	MAGIC‐DR: An interpretable machine‐learning guided approach for acute myeloid leukemia measurable residual disease analysis 2024 ·Cytometry Part B Clinical Cytometry ·Kevin E. Shopsowitz,(unknown),Geoffrey Chan,(unknown),(unknown),Ryan R. Brinkman,Andrew P. Weng,(unknown),Xuehai Wang	6
3	Modeling of Li-ion Battery Thermal Runaway: Insights into Modeling and Prediction 2024 ·The Electrochemical Society Interface ·Paul T. Coman,Andrew P. Weng,Jason K. Ostanek,Eric Darcy,Donal P. Finegan,Ralph E. White	4
4	Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL 2022 ·Blood ·(unknown),Nadine Fournier,(unknown),João Lourenço,Yuanlong Liu,(unknown),Christelle Dubey,(unknown),Colin E.J. Pritchard,Ivo J. Huijbers,(unknown),(unknown),(unknown),Laura Belver,Adolfo A. Ferrando,Giovanni Ciriello,Andrew P. Weng,Ute Koch,Freddy Radtke	9
5	Immune Profiling of Diagnostic DLBCL Biopsies Dramatically Improves upon Cell-of-Origin Risk Stratification 2021 ·Blood ·Michael Nissen,Xuehai Wang,Clémentine Sarkozy,Aixiang Jiang,Daisuke Ennishi,Tomohiro Aoki,Stacy Hung,Elizabeth A. Chavez,Jeffrey W. Craig,Pedro Farinha,Graham W. Slack,David W. Scott,Christian Steidl,Andrew P. Weng	0
6	MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus 2020 ·Blood ·(unknown),Davide Pellacani,Naoto Nakamichi,Colin A. Hammond,Philip Beer,Alireza Lorzadeh,Michelle Moksa,Annaïck Carles,Misha Bilenky,Sylvain Lefort,(unknown),Brian T. Wilhelm,Andrew P. Weng,Martin Hirst,Connie J. Eaves	18
7	RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes 2018 ·Experimental Hematology ·Catherine E. Jenkins,Samuel Gusscott,Rachel Wong,Olena O Shevchuk,(unknown),Vincenzo Giambra,(unknown),(unknown),Martin Hirst,Andrew P. Weng	4
8	Epigenetic Restoration of Fetal-like IGF1 Signaling Inhibits Leukemia Stem Cell Activity 2018 ·Cell stem cell ·Vincenzo Giambra,Samuel Gusscott,(unknown),(unknown),Sonya H.L. Lam,(unknown),(unknown),Catherine E. Jenkins,(unknown),Alireza Lorzadeh,Annaïck Carles,Martin Hirst,Connie J. Eaves,Andrew P. Weng	17
9	Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2 2017 ·Molecular Cancer Therapeutics ·Louis‐Bastien Weiswald,Mohammad R. Hasan,John C.T. Wong,(unknown),Mahbuba Rahman,Jianhua Ren,(unknown),Samuel Gusscott,Sophie Vacher,Andrew P. Weng,Hagen F. Kennecke,Ivan Bièche,David F. Schaeffer,Donald T. Yapp,Isabella T. Tai	17
10	Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia 2017 ·Experimental Hematology ·Takayo Sasaki,Juan Carlos Rivera‐Mulia,Daniel L. Vera,(unknown),(unknown),Michelle R. Padget,Naoto Nakamichi,Bill H. Chang,(unknown),Brian Druker,Andrew P. Weng,Curt I. Civin,Connie J. Eaves,David M. Gilbert	21
11	Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia 2014 ·Haematologica ·Victoria L. Bentley,Chansey J. Veinotte,Dale Corkery,Jordan Pinder,Marissa A. LeBlanc,Karen Bedard,Andrew P. Weng,Jason N. Berman,Graham Dellaire	83
12	IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein 2012 ·Experimental Hematology ·Catherine E. Jenkins,Olena O Shevchuk,Vincenzo Giambra,Sonya H.L. Lam,Joan M. Carboni,Marco M. Gottardis,Martin Holzenberger,Michaël Pollak,R. Keith Humphries,Andrew P. Weng	17
13	NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growthbreakdown → 2006 ·Proceedings of the National Academy of Sciences ·Teresa Palomero,Wei Keat Lim,Duncan T. Odom,Maria Luisa Sulis,Pedro J. Real,Adam A. Margolin,Kelly Barnes,Jennifer O’Neil,Donna Neuberg,Andrew P. Weng,Jon C. Aster,François Sigaux,Jean Soulier,A. Thomas Look,Richard A. Young,Andrea Califano,Adolfo A. Ferrando	639
14	Mastermind critically regulates Notch-mediated lymphoid cell fate decisions 2004 ·Blood ·Ivan Maillard,Andrew P. Weng,Andrea C. Carpenter,Carlos G. Rodríguez,Hong Sai,Lanwei Xu,David Allman,Jon C. Aster,Warren S. Pear	235
15	Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemiabreakdown → 2004 ·Science ·Andrew P. Weng,Adolfo A. Ferrando,Woojoong Lee,John P. Morris,Lewis B. Silverman,Cheryll Sanchez-Irizarry,Stephen C. Blacklow,A. Thomas Look,Jon C. Aster	2013
16	Notch Subunit Heterodimerization and Prevention of Ligand-Independent Proteolytic Activation Depend, Respectively, on a Novel Domain and the LNR Repeats 2004 ·Molecular and Cellular Biology ·Cheryll Sanchez-Irizarry,Andrea C. Carpenter,Andrew P. Weng,Warren S. Pear,Jon C. Aster,Stephen C. Blacklow	163
17	Modified Magrath Regimens for Adults with Burkitt and Burkitt-Like Lymphomas: Preserved Efficacy with Decreased Toxicity 2003 ·Leukemia & lymphoma ·Ann S. LaCasce,O. M. Zack Howard,S Li,David C. Fisher,Andrew P. Weng,Donna Neuberg,Margaret A. Shipp	83
18	No T without D3 2003 ·Cancer Cell ·Andrew P. Weng,Jon C. Aster	6
19	Deltex1 Redirects Lymphoid Progenitors to the B Cell Lineage by Antagonizing Notch1 2002 ·Immunity ·David J. Izon,Jon C. Aster,Yiping He,Andrew P. Weng,Fredrick G. Karnell,(unknown),Lanwei Xu,Sonia Bakkour,Carlos E. Rodríguez,David Allman,Warren S. Pear	211
20	The Bulk Chromatin Structure of a Murine Transgene Does Not Vary with Its Transcriptional or DNA Methylation Status 1995 ·Molecular and Cellular Biology ·Andrew P. Weng,Peter Engler,Ursula Storb	15

About Andrew P. Weng

Andrew P. Weng is a scholar working on Hematology, Pathology and Forensic Medicine and Immunology, having authored 100 papers that have together received 9.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (28 papers), Acute Lymphoblastic Leukemia research (20 papers) and Epigenetics and DNA Methylation (16 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (924 citations) and Molecular Biology (5.7k citations). Andrew P. Weng has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Jon C. Aster, Stephen C. Blacklow, Adolfo A. Ferrando, A. Thomas Look, Cheryll Sanchez-Irizarry, Lewis B. Silverman, John P. Morris, Woojoong Lee, Warren S. Pear and Donna Neuberg. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact